Effectiveness of tyrosine kinase inhibitors on uncommon E709X epidermal growth factor receptor mutations in non-small-cell lung cancer

BACKGROUND: Clinical features of epidermal growth factor receptor (EGFR) mutations: L858R, deletions in exon 19, T790M, insertions in exon 20, G719X, and L861X in non-small-cell lung cancer (NSCLC) are well-known. The clinical significance of other uncommon EGFR mutations, such as E709X, is not well...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jenn-Yu, Shih, Jin-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067004/
https://www.ncbi.nlm.nih.gov/pubmed/27785061
http://dx.doi.org/10.2147/OTT.S118071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067004/
https://www.ncbi.nlm.nih.gov/pubmed/27785061
http://dx.doi.org/10.2147/OTT.S118071

Ejemplares similares